TP53 and cancer: In combination with cisplatin, Oligo-Fucoidan still promoted cancer cell death through increasing p53-p21 signaling (Supplementary Figure S6A), PARP cleavage and caspase-3 activation (Figure 4C and Figure 5A), which may cause the cytotoxicity.